URAC Opioid Stewardship Designation vs. Other Opioid Programs

Last updated: April 2026

Organizations managing opioid medications encounter multiple overlapping frameworks: URAC's Opioid Stewardship Designation, Joint Commission opioid standards embedded in hospital accreditation, NABP pharmacy program requirements, state prescription drug monitoring program (PDMP) mandates, and CMS opioid utilization management requirements. This page clarifies what each framework covers, who it applies to, and how they interact — so your organization can make an informed decision about which credentials and compliance programs to pursue. IHS is led by Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC.

The Landscape: Multiple Frameworks, Different Purposes

No single opioid stewardship framework governs all healthcare organizations. The applicable frameworks depend on your organization type, accreditation portfolio, payer contracts, and state regulatory environment. The key frameworks in the pharmacy and health plan space are:

• URAC Opioid Stewardship Designation — voluntary add-on for URAC-accredited pharmacy, health plan, and patient care management organizations
• Joint Commission Opioid Stewardship Standards — mandatory standards embedded in Joint Commission hospital accreditation (NPSG.03.11.01)
• NABP Pharmacy Accreditation Requirements — opioid-related requirements embedded in NABP VAWD and other pharmacy accreditation programs
• CMS Opioid Utilization Management Requirements — Part D sponsor requirements for formulary controls, quantity limits, and prior authorization on opioids
• State PDMP and Regulatory Mandates — prescriber registration, dispenser reporting, and patient safety requirements varying by state
• NCQA Health Plan Opioid Standards — opioid-related utilization management and care management standards within NCQA Health Plan Accreditation

These frameworks are not alternatives to each other. Depending on your organization's accreditation portfolio and operating context, you may be subject to multiple frameworks simultaneously. The question is not "which one should we choose" — it is "which frameworks apply to us, and how do we satisfy them efficiently?"

URAC Opioid Stewardship Designation vs. Joint Commission Opioid Standards

What Each Covers

The URAC Opioid Stewardship Designation is a four-standard add-on designation for organizations in the pharmacy and health plan space — specialty pharmacies, PBMs, mail service pharmacies, health plans, and patient care management organizations. It is voluntary, supplements existing URAC accreditation, and is evaluated through URAC's desktop review process against URAC's interpretive information.

The Joint Commission Opioid Stewardship Standard (NPSG.03.11.01) is a mandatory National Patient Safety Goal embedded within Joint Commission hospital accreditation. It requires hospitals to collect and analyze data on opioid prescribing, identify high-risk patients, implement non-opioid pain management alternatives, and provide staff education. It applies to Joint Commission-accredited hospitals and critical access hospitals — not to pharmacies or PBMs operating outside a hospital setting.

Key Differences

Which Applies to My Organization?

If your organization is a standalone specialty pharmacy, PBM, or health plan: URAC's Opioid Stewardship Designation is the relevant credential framework. Joint Commission opioid standards apply only if your organization holds Joint Commission hospital accreditation.

If your organization is a hospital system with an in-house specialty pharmacy: Joint Commission opioid standards apply to your hospital operations. If your specialty pharmacy also seeks URAC Specialty Pharmacy Accreditation, the URAC Opioid Stewardship Designation may apply to the pharmacy entity.

URAC Opioid Stewardship Designation vs. NABP Pharmacy Requirements

What Each Covers

The URAC Opioid Stewardship Designation is a supplementary credential within URAC's accreditation ecosystem. It is available to any URAC-accredited pharmacy organization whose operations touch opioid patient access.

NABP (National Association of Boards of Pharmacy) operates its own pharmacy accreditation programs — including NABP VAWD (Verified-Accredited Wholesale Distributors) for wholesale distributors and NABP DMEPOS for durable medical equipment suppliers. NABP accreditation programs incorporate controlled substance handling requirements, but NABP does not offer a standalone opioid stewardship designation analogous to URAC's.

For retail and community pharmacies, NABP's primary tools are the NABP e-Profile and state board reporting — not a designation-level credential for opioid stewardship.

Key Differences

If We Already Have NABP Accreditation, Do We Need the URAC Designation?

NABP and URAC credentials are recognized by different payers and serve different contracting contexts. The URAC Opioid Stewardship Designation adds value specifically for organizations whose payer contracts, network agreements, or state contracts reference URAC credentials. If your contracts are NABP-referenced only, the marginal value of the URAC designation is a market positioning decision, not a compliance requirement. IHS advises on this during initial eligibility consultation.

URAC Opioid Stewardship Designation vs. CMS Part D Opioid Requirements

What Each Covers

CMS Part D opioid utilization management requirements are mandatory federal requirements for Medicare Part D plan sponsors. They include coverage limits on initial opioid fills, drug management programs (DMPs) for at-risk beneficiaries, safety edits at the point of sale, and formulary restrictions on certain opioid formulations. These are regulatory compliance requirements — failure results in CMS enforcement, not accreditation deficiency.

The URAC Opioid Stewardship Designation is an organizational credential that demonstrates systematic opioid stewardship commitment beyond minimum regulatory compliance. For Medicare Part D plan sponsors already subject to CMS opioid requirements, the URAC designation documents that the organization's stewardship programs meet an independently reviewed standard.

Relationship Between the Two

CMS Part D opioid requirements set the regulatory floor. The URAC designation operates above that floor — it is not a substitute for CMS compliance but can reinforce it. Organizations that have built robust internal programs to satisfy CMS requirements often find the URAC designation requires limited additional work, because the operational infrastructure (monitoring, escalation, patient safety protocols) is already in place. The designation then provides an externally validated credential that payers and partners can reference.

Critically: satisfying CMS Part D requirements does not automatically satisfy URAC's four designation standards. URAC's interpretive information governs what evidence the designation review evaluates — and it is not identical to CMS's regulatory framework.

URAC Opioid Stewardship Designation vs. NCQA Health Plan Opioid Standards

What Each Covers

NCQA Health Plan Accreditation incorporates utilization management and care management standards that apply to opioid prescribing and opioid use disorder treatment — including prior authorization standards, opioid treatment program (OTP) coverage requirements, and SUD care management integration. These are embedded within NCQA's full health plan accreditation standard set, not a separate designation.

The URAC Opioid Stewardship Designation is available to health plan organizations pursuing URAC Health Plan Accreditation as an add-on to their primary URAC credential. It provides a distinct, named opioid stewardship credential that NCQA health plan accreditation does not offer.

For Health Plans: Which Accreditation Body and Which Opioid Framework?

Health plans selecting between URAC and NCQA accreditation make that decision based on state mandates, payer contracting requirements, and program offerings — not opioid stewardship specifically. (26 states require NCQA Health Plan Accreditation for Medicaid managed care; URAC health plan accreditation is recognized in different state and commercial contracting contexts.) Once the primary accreditation body is selected, the opioid stewardship framework follows accordingly.

Health plans pursuing URAC Health Plan Accreditation can add the Opioid Stewardship Designation. Health plans pursuing NCQA accreditation satisfy opioid-related standards through NCQA's embedded utilization management and care management requirements — there is no separate NCQA opioid designation.

Decision Framework: Which Opioid Framework(s) Apply to You?

Step 1: Identify Your Primary Accreditation Portfolio

• URAC-accredited (Specialty Pharmacy, PBM, Health Plan, Patient Care Management, Digital Health) → URAC Opioid Stewardship Designation is available and potentially valuable
• Joint Commission-accredited hospital → NPSG.03.11.01 is mandatory; URAC designation may additionally apply to outpatient pharmacy entities
• NCQA-accredited health plan → Opioid requirements are embedded in NCQA standards; no separate designation available
• NABP-accredited → No standalone NABP opioid designation; URAC designation is separately available if URAC accreditation is held or pursued

Step 2: Identify Your Regulatory Compliance Obligations

• Medicare Part D plan sponsor → CMS opioid utilization management requirements apply; URAC designation can complement but does not substitute
• Medicaid managed care plan in a state requiring NCQA Health Plan Accreditation → NCQA standards apply; URAC is additive, not required
• State-licensed pharmacy → State PDMP reporting, dispensing limits, and prescriber education requirements apply regardless of accreditation

Step 3: Evaluate Market Positioning

After confirming applicable frameworks, the strategic question is whether the URAC Opioid Stewardship Designation adds market value for your specific contracting environment. IHS advises on this assessment during initial consultation — the answer depends on what your primary payer and contracting relationships require or prefer, not on a generic recommendation.

How IHS Advises on Multi-Framework Opioid Stewardship

Most pharmacy and health plan organizations navigating opioid stewardship operate across multiple frameworks simultaneously. A specialty pharmacy holding URAC accreditation and contracting with Medicare Part D plans is subject to both URAC's Opioid Stewardship Designation standards and CMS Part D opioid requirements. A hospital system with an in-house specialty pharmacy may simultaneously navigate Joint Commission hospital standards and URAC pharmacy designation criteria.

IHS does not evaluate opioid stewardship in isolation. Our engagement begins by mapping your complete accreditation portfolio and regulatory obligations, identifying where frameworks overlap, and designing an integrated compliance program that satisfies multiple requirements without redundant documentation effort.

Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC — brings both the URAC-specific expertise and the cross-framework regulatory knowledge necessary to navigate this landscape efficiently.

Related Resources

• URAC Opioid Stewardship Designation Consulting — overview of IHS's engagement approach
• URAC Opioid Stewardship Designation FAQ — detailed answers to 14 common questions
• URAC Specialty Pharmacy Accreditation Consulting
• URAC Pharmacy Benefit Management Accreditation Consulting
• URAC Health Plan Accreditation Consulting
• Compliance Program Development — for organizations building opioid stewardship infrastructure outside of an accreditation cycle

Not Sure Which Framework Applies to You?

IHS will assess your accreditation portfolio, regulatory obligations, and contracting environment and give you a clear picture of which opioid stewardship frameworks apply — and the most efficient path to satisfying them.

Schedule a Free Discovery Session